Additional Treatment with Fenofibrate for Patients Treated with Pitavastatin Under Ordinary Medical Practice for Hypertriglyceridemia in Japan (APPROACH-J Study)

Safety and efficacy of combination therapy of pitavastatin and fenofibrate were examined in consecutive case series with fasting serum triglycerides ≥ 150 mg/dL despite receiving pitavastatin 1 or 2 mg daily for over 2 months and additionally administered micronized fenofibrate 67 mg daily for anoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakida, Yasushi, Suzuki, Satoshi, Nomura, Hirohiko, Isomura, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699489/
https://www.ncbi.nlm.nih.gov/pubmed/23885192
http://dx.doi.org/10.4137/JCM.S7863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699489/
https://www.ncbi.nlm.nih.gov/pubmed/23885192
http://dx.doi.org/10.4137/JCM.S7863

Ejemplares similares